(Q48254604)

10 February 2018

title

Natural history and management of low-grade glioma in NF-1 children. (English)

1 reference

10 February 2018

author

Stephan von Hornstein

2

object named as

Stephan von Hornstein

1 reference

10 February 2018

5

Monika Warmuth-Metz

1 reference

10 February 2018

Pablo Hernáiz Driever

1

1 reference

10 February 2018

Torsten Pietsch

3

1 reference

10 February 2018

Rolf Kortmann

4

1 reference

10 February 2018

Angela Emser

6

1 reference

10 February 2018

Astrid K Gnekow

7

1 reference

10 February 2018

publication date

30 March 2010

1 reference

10 February 2018

Journal of Neuro-Oncology

published in

1 reference

10 February 2018

volume

100

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

page(s)

199-207

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1007/s11060-010-0159-z

exact match

0 references

cites work

MRI and clinical differences between optic pathway tumours in children with and without neurofibromatosis.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0159-Z

Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0159-Z

Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0159-Z

Late-onset optic pathway tumors in children with neurofibromatosis 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0159-Z

Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0159-Z

Intracranial gliomas in neurofibromatosis type 1.

21 January 2018

1 reference

12 December 2020

Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.

1 reference

12 December 2020

Moyamoya phenomenon after radiation for optic glioma

1 reference

12 December 2020

Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade g

1 reference

12 December 2020

A prospective study of neurofibromatosis type 1 cancer incidence in the UK.

1 reference

12 December 2020

Cerebellar gliomas in children with NF1: pathology and surgery.

1 reference

12 December 2020

[HIT-LGG: effectiveness of carboplatin-vincristine in progressive low-grade gliomas of childhood--an interim report]

1 reference

12 December 2020

Intracranial neoplasms in children with neurofibromatosis 1.

1 reference

12 December 2020

Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1.

1 reference

12 December 2020

A prospective 10 year follow up study of patients with neurofibromatosis type 1

1 reference

12 December 2020

Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma.

1 reference

12 December 2020

Hemispheric cerebral gliomas in children with NF1: arguments for a long-term follow-up.

1 reference

12 December 2020

High response rate to cisplatin/etoposide regimen in childhood low-grade glioma

1 reference

12 December 2020

The role of surgical biopsy in the diagnosis of glioma in individuals with neurofibromatosis-1.

1 reference

12 December 2020

Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients.

1 reference

12 December 2020

Recent advances in neurofibromatosis type 1.

1 reference

12 December 2020

Malignancy in neurofibromatosis type 1.

1 reference

12 December 2020

Prognostic factors for progression of childhood optic pathway glioma: a systematic review

1 reference

12 December 2020

Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy--results of the first French prospective study for the French Society of Pediatric Oncology

1 reference

12 December 2020

Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy.

1 reference

12 December 2020

Gliomas of the optic nerves.

1 reference

12 December 2020

Neoplasms in neurofibromatosis 1 are related to gender but not to family history of cancer.

1 reference

12 December 2020

Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up

1 reference

12 December 2020

Recommendations of the Brain Tumor Subcommittee for the reporting of trials. SIOP Brain Tumor Subcommittee. International Society of Pediatric Oncology.

1 reference

12 December 2020

Initial management of children with hypothalamic and thalamic tumors and the modifying role of neurofibromatosis-1.

1 reference

12 December 2020

Spontaneous regression of optic pathways gliomas in three patients with neurofibromatosis type I and critical review of the literature

1 reference

12 December 2020

Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.

1 reference

12 December 2020

Interstitial radiosurgery of low-grade gliomas.

1 reference

12 December 2020

10.1007/S11060-010-0159-Z

Identifiers

DOI

1 reference

10 February 2018

release_dlv5pdvzyfgbzpssmldgbu7ypq

Fatcat ID

0 references

PubMed ID

20352473

1 reference

10 February 2018